Therefore, to test the potential use of serum ANGPTL4 levels as a biomarker for correlative diagnosis of acute ischemic stroke, we analyzed the serum levels in blood samples taken from a small cohort of patients within one day of an ischemic stroke event. This evidence concerns the gene ANGPTL4 and ischemic stroke.